The impact of additional treatment after endoscopic submucosal dissection for esophageal squamous cell carcinoma in real-world clinical practice.

Nanako Sakaguchi,Toshifumi Yamaguchi,Yasunobu Ishizuka,Hiroyuki Kodama,Takahiro Miyamoto,Tetsuji Terazawa,Yuichi Kojima,Takayuki Kii,Makoto Sanomura,Masahiro Goto,Kazuhide Higuchi

The impact of additional treatment after endoscopic submucosal dissection for esophageal squamous cell carcinoma in real-world clinical practice.

2020

Nanako Sakaguchi
Toshifumi Yamaguchi
Yasunobu Ishizuka
Hiroyuki Kodama
Takahiro Miyamoto
Tetsuji Terazawa
Yuichi Kojima
Takayuki Kii
Makoto Sanomura
Masahiro Goto
Kazuhide Higuchi

305Background: Endoscopic submucosal dissection (ESD) is the standard therapy for the T1a- EP/LPM esophageal squamous cell carcinoma (ESCC), although it is difficult to diagnose the invasion depth ...

Keywords:

Endoscopic submucosal dissection
esophageal squamous cell carcinoma
Medicine
Clinical Practice
Radiology
Pathology
invasion depth
standard therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations